TCL Archive Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts November 23, 1974
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006